B
B Almeida Lopes
Publications - 3
Citations - 482
B Almeida Lopes is an academic researcher. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 1, co-authored 1 publications receiving 313 citations.
Papers
More filters
Journal ArticleDOI
The MLL recombinome of acute leukemias in 2017
Christian Meyer,Thomas Burmeister,Daniela Gröger,Grigory Tsaur,L Fechina,Aline Renneville,Rosemary Sutton,Nicola C. Venn,Mariana Emerenciano,Maria S. Pombo-de-Oliveira,C Barbieri Blunck,B Almeida Lopes,Jan Zuna,Jan Trka,Paola Ballerini,Hélène Lapillonne,M. De Braekeleer,Giovanni Cazzaniga,L Corral Abascal,V H J van der Velden,Eric Delabesse,T S Park,S H Oh,Maria Luiza Macedo Silva,T Lund-Aho,Vesa Juvonen,Andrew S. Moore,Olaf Heidenreich,Josef Vormoor,Elena Zerkalenkova,Yulia Olshanskaya,Clara Bueno,Clara Bueno,Pablo Menendez,Pablo Menendez,Andrea Teigler-Schlegel,U zur Stadt,Jana Lentes,Gudrun Göhring,Anatoly Kustanovich,Olga Aleinikova,Beat W. Schäfer,S Kubetzko,Hans O. Madsen,Bernd Gruhn,X Duarte,Paula Gameiro,Eric Lippert,A Bidet,J M Cayuela,Emmanuelle Clappier,Cristina N. Alonso,Christian M. Zwaan,M M van den Heuvel-Eibrink,Shai Izraeli,Shai Izraeli,L. Trakhtenbrot,L. Trakhtenbrot,P Archer,Jeremy Hancock,Anja Möricke,Julia Alten,Martin Schrappe,Martin Stanulla,Sabine Strehl,Andishe Attarbaschi,Michael Dworzak,Oskar A. Haas,Renate Panzer-Grümayer,Lukasz Sedek,Tomasz Szczepański,Aurélie Caye,L Suarez,Hélène Cavé,Rolf Marschalek +74 more
TL;DR: This study provides a comprehensive analysis of the MLL recombinome in acute leukemia and demonstrates that the establishment of patient-specific chromosomal fusion sites allows the design of specific PCR primers for minimal residual disease analyses for all patients.
Journal ArticleDOI
The KMT2A recombinome of acute leukemias in 2023
Claus Meyer,Patrizia Larghero,B Almeida Lopes,Thomas Burmeister,Daniela Gröger,Rosemary Sutton,Nicola C. Venn,Giovanni Cazzaniga,L Corral Abascal,G Tsaur,L Fechina,Mariana Emerenciano,Maria S. Pombo-de-Oliveira,T Lund-Aho,Tuija Lundán,Mia Montonen,Vesa Juvonen,Jan Zuna,Jan Trka,Paola Ballerini,Hélène Lapillonne,V H J van der Velden,Edwin Sonneveld,Eric Delabesse,R. R. C. de Matos,M. L. M. Silva,Simon Bomken,Katerina Katsibardi,Maria Keernik,Nathalie Grardel,J Mason,Rebecca Faulkner Price,C Eckert,Luca Lo Nigro,Clara Bueno,P. Menéndez,Udo zur Stadt,P. Gameiro,Lukasz Sedek,Tomasz Szczepański,A Bidet,Victoria Marcu,Keren Shichrur,Shai Izraeli,Hans O. Madsen,Beat W. Schäfer,Susanne Kubetzko,Rathana Kim,Emmanuelle Clappier,Heiko Trautmann,Monika Brüggemann,P. Archer,J. Hancock,Julia Alten,Anja Möricke,Martin Stanulla,Jana Lentes,Anke K. Bergmann,Sabine Strehl,Stefan Köhrer,Karin Nebral,M Dworzak,Oskar A. Haas,Chloé Arfeuille,Aurélie Caye-Eude,Hélène Cavé,Rolf Marschalek +66 more
TL;DR: In this article , a comprehensive analysis of the KMT2A recombinome in acute leukemia patients was provided, and genomic breakpoint sequences of these patients were used to monitor minimal residual disease (MRD).
Journal ArticleDOI
Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome Presenting t(11;16)(q23;q24)
Viviane Lamim Lovatel,Luize Otero,Ercole Pietro Orlando,Claudia Diniz,Filipe V. dos Santos-Bueno,B Almeida Lopes,Elaiza Almeida Antônio de Kós,Monica Kopischitz Praxedes Lusis,Eliana Abdelhay,Teresa de Souza Fernandez +9 more
TL;DR: Treatment refractoriness and leukemia transformation suggest that t(11;16)(q23;q24) with KMT2A-r was associated with poor prognosis, which reinforces the importance of characterizing new chromosomal alterations and their impact on prognosis in MDS.